Cargando…

CEACAM1 Is Associated With the Suppression of Natural Killer Cell Function in Patients With Chronic Hepatitis C

Natural killer cells (NK cells) play an essential role in the immunological mechanism underlying chronic hepatitis C (CHC). Impairment of NK cell function facilitates persistent infection with hepatitis C virus (HCV) and hepatocellular carcinogenesis. However, the mechanism by which NK cell activity...

Descripción completa

Detalles Bibliográficos
Autores principales: Suda, Takahiro, Tatsumi, Tomohide, Nishio, Akira, Kegasawa, Tadashi, Yoshioka, Teppei, Yamada, Ryoko, Furuta, Kunimaro, Kodama, Takahiro, Shigekawa, Minoru, Hikita, Hayato, Sakamori, Ryotaro, Fukuhara, Takasuke, Matsuura, Yoshiharu, Takehara, Tetsuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6167072/
https://www.ncbi.nlm.nih.gov/pubmed/30288478
http://dx.doi.org/10.1002/hep4.1240
_version_ 1783360139223367680
author Suda, Takahiro
Tatsumi, Tomohide
Nishio, Akira
Kegasawa, Tadashi
Yoshioka, Teppei
Yamada, Ryoko
Furuta, Kunimaro
Kodama, Takahiro
Shigekawa, Minoru
Hikita, Hayato
Sakamori, Ryotaro
Fukuhara, Takasuke
Matsuura, Yoshiharu
Takehara, Tetsuo
author_facet Suda, Takahiro
Tatsumi, Tomohide
Nishio, Akira
Kegasawa, Tadashi
Yoshioka, Teppei
Yamada, Ryoko
Furuta, Kunimaro
Kodama, Takahiro
Shigekawa, Minoru
Hikita, Hayato
Sakamori, Ryotaro
Fukuhara, Takasuke
Matsuura, Yoshiharu
Takehara, Tetsuo
author_sort Suda, Takahiro
collection PubMed
description Natural killer cells (NK cells) play an essential role in the immunological mechanism underlying chronic hepatitis C (CHC). Impairment of NK cell function facilitates persistent infection with hepatitis C virus (HCV) and hepatocellular carcinogenesis. However, the mechanism by which NK cell activity is suppressed in CHC is not completely understood. In this study, we focused on carcinoembryonic antigen–related cell‐adhesion molecule 1 (CEACAM1). CEACAM1 is thought to suppress NK cell function. We examined the effect of CEACAM1 on NK cell function in CHC. We investigated the function of CEACAM1 in vitro using Huh7.5.1 cells and the HCV‐Japanese fulminant hepatitis (JFH)‐1 strain. We analyzed serum CEACAM1 level, NK cell function, and CEACAM1 messenger RNA (mRNA) level in human liver samples. Levels of CEACAM1 on the cell surface, CEACAM1 mRNA levels, and soluble CEACAM1 levels in supernatants were significantly higher in Huh7.5.1 cells infected with JFH‐1 (Huh7.5.1/JFH‐1 cells) than in Huh7.5.1 cells. Significantly higher NK cell cytotoxicity was observed toward K562 cells after coculture with CEACAM1 knockout Huh7.5.1/JFH‐1 cells than after coculture with Huh7.5.1/JFH‐1 cells. CEACAM1 expression was induced by the HCV E2 glycoprotein in HCV infection. Significantly higher serum CEACAM1 levels were detected in patients with CHC compared with healthy subjects and patients who achieved sustained virological responses. The expression of CD107a on NK cells from patients with CHC was negatively correlated with serum CEACAM1 levels. Significantly higher levels of CEACAM1 mRNA were detected in HCV‐infected livers compared with uninfected livers. Conclusion: CEACAM1 expression was induced in hepatocytes following HCV infection and decreased NK cell cytotoxicity. These results demonstrate a possible role for CEACAM1 in the pathogenesis of CHC and hepatocellular carcinoma progression.
format Online
Article
Text
id pubmed-6167072
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-61670722018-10-04 CEACAM1 Is Associated With the Suppression of Natural Killer Cell Function in Patients With Chronic Hepatitis C Suda, Takahiro Tatsumi, Tomohide Nishio, Akira Kegasawa, Tadashi Yoshioka, Teppei Yamada, Ryoko Furuta, Kunimaro Kodama, Takahiro Shigekawa, Minoru Hikita, Hayato Sakamori, Ryotaro Fukuhara, Takasuke Matsuura, Yoshiharu Takehara, Tetsuo Hepatol Commun Original Articles Natural killer cells (NK cells) play an essential role in the immunological mechanism underlying chronic hepatitis C (CHC). Impairment of NK cell function facilitates persistent infection with hepatitis C virus (HCV) and hepatocellular carcinogenesis. However, the mechanism by which NK cell activity is suppressed in CHC is not completely understood. In this study, we focused on carcinoembryonic antigen–related cell‐adhesion molecule 1 (CEACAM1). CEACAM1 is thought to suppress NK cell function. We examined the effect of CEACAM1 on NK cell function in CHC. We investigated the function of CEACAM1 in vitro using Huh7.5.1 cells and the HCV‐Japanese fulminant hepatitis (JFH)‐1 strain. We analyzed serum CEACAM1 level, NK cell function, and CEACAM1 messenger RNA (mRNA) level in human liver samples. Levels of CEACAM1 on the cell surface, CEACAM1 mRNA levels, and soluble CEACAM1 levels in supernatants were significantly higher in Huh7.5.1 cells infected with JFH‐1 (Huh7.5.1/JFH‐1 cells) than in Huh7.5.1 cells. Significantly higher NK cell cytotoxicity was observed toward K562 cells after coculture with CEACAM1 knockout Huh7.5.1/JFH‐1 cells than after coculture with Huh7.5.1/JFH‐1 cells. CEACAM1 expression was induced by the HCV E2 glycoprotein in HCV infection. Significantly higher serum CEACAM1 levels were detected in patients with CHC compared with healthy subjects and patients who achieved sustained virological responses. The expression of CD107a on NK cells from patients with CHC was negatively correlated with serum CEACAM1 levels. Significantly higher levels of CEACAM1 mRNA were detected in HCV‐infected livers compared with uninfected livers. Conclusion: CEACAM1 expression was induced in hepatocytes following HCV infection and decreased NK cell cytotoxicity. These results demonstrate a possible role for CEACAM1 in the pathogenesis of CHC and hepatocellular carcinoma progression. John Wiley and Sons Inc. 2018-09-25 /pmc/articles/PMC6167072/ /pubmed/30288478 http://dx.doi.org/10.1002/hep4.1240 Text en © 2018 The Authors. Hepatology Communications published by Wiley Periodicals, Inc., on behalf of the American Association for the Study of Liver Diseases. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Original Articles
Suda, Takahiro
Tatsumi, Tomohide
Nishio, Akira
Kegasawa, Tadashi
Yoshioka, Teppei
Yamada, Ryoko
Furuta, Kunimaro
Kodama, Takahiro
Shigekawa, Minoru
Hikita, Hayato
Sakamori, Ryotaro
Fukuhara, Takasuke
Matsuura, Yoshiharu
Takehara, Tetsuo
CEACAM1 Is Associated With the Suppression of Natural Killer Cell Function in Patients With Chronic Hepatitis C
title CEACAM1 Is Associated With the Suppression of Natural Killer Cell Function in Patients With Chronic Hepatitis C
title_full CEACAM1 Is Associated With the Suppression of Natural Killer Cell Function in Patients With Chronic Hepatitis C
title_fullStr CEACAM1 Is Associated With the Suppression of Natural Killer Cell Function in Patients With Chronic Hepatitis C
title_full_unstemmed CEACAM1 Is Associated With the Suppression of Natural Killer Cell Function in Patients With Chronic Hepatitis C
title_short CEACAM1 Is Associated With the Suppression of Natural Killer Cell Function in Patients With Chronic Hepatitis C
title_sort ceacam1 is associated with the suppression of natural killer cell function in patients with chronic hepatitis c
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6167072/
https://www.ncbi.nlm.nih.gov/pubmed/30288478
http://dx.doi.org/10.1002/hep4.1240
work_keys_str_mv AT sudatakahiro ceacam1isassociatedwiththesuppressionofnaturalkillercellfunctioninpatientswithchronichepatitisc
AT tatsumitomohide ceacam1isassociatedwiththesuppressionofnaturalkillercellfunctioninpatientswithchronichepatitisc
AT nishioakira ceacam1isassociatedwiththesuppressionofnaturalkillercellfunctioninpatientswithchronichepatitisc
AT kegasawatadashi ceacam1isassociatedwiththesuppressionofnaturalkillercellfunctioninpatientswithchronichepatitisc
AT yoshiokateppei ceacam1isassociatedwiththesuppressionofnaturalkillercellfunctioninpatientswithchronichepatitisc
AT yamadaryoko ceacam1isassociatedwiththesuppressionofnaturalkillercellfunctioninpatientswithchronichepatitisc
AT furutakunimaro ceacam1isassociatedwiththesuppressionofnaturalkillercellfunctioninpatientswithchronichepatitisc
AT kodamatakahiro ceacam1isassociatedwiththesuppressionofnaturalkillercellfunctioninpatientswithchronichepatitisc
AT shigekawaminoru ceacam1isassociatedwiththesuppressionofnaturalkillercellfunctioninpatientswithchronichepatitisc
AT hikitahayato ceacam1isassociatedwiththesuppressionofnaturalkillercellfunctioninpatientswithchronichepatitisc
AT sakamoriryotaro ceacam1isassociatedwiththesuppressionofnaturalkillercellfunctioninpatientswithchronichepatitisc
AT fukuharatakasuke ceacam1isassociatedwiththesuppressionofnaturalkillercellfunctioninpatientswithchronichepatitisc
AT matsuurayoshiharu ceacam1isassociatedwiththesuppressionofnaturalkillercellfunctioninpatientswithchronichepatitisc
AT takeharatetsuo ceacam1isassociatedwiththesuppressionofnaturalkillercellfunctioninpatientswithchronichepatitisc